Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2003

01-10-2003

Regulation of ghrelin secretion and action

Authors: Jesus P. Camiña, Marcos C. Carreira, Dragan Micic, Manuel Pombo, Fahrettin Kelestimur, Carlos Dieguez, Prof. Felipe F. Casanueva

Published in: Endocrine | Issue 1/2003

Login to get access
Metadata
Title
Regulation of ghrelin secretion and action
Authors
Jesus P. Camiña
Marcos C. Carreira
Dragan Micic
Manuel Pombo
Fahrettin Kelestimur
Carlos Dieguez
Prof. Felipe F. Casanueva
Publication date
01-10-2003
Publisher
Humana Press
Published in
Endocrine / Issue 1/2003
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:22:1:5

Other articles of this Issue 1/2003

Endocrine 1/2003 Go to the issue

OriginalPaper

Targeting the ghrelin receptor

OriginalPaper

Current topics in GH secretagogue research—Introduction

OriginalPaper

Ghrelin and the endocrine pancreas

OriginalPaper

Fibromyalgia

OriginalPaper

Neuropeptide Y

OriginalPaper

Growth hormone-releasing hormone and growth hormone secretagogues in normal aging
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits